Physician
Nazneen, Ruksana
Nazneen, Ruksana was paid $1.61M by Medicaid between Jan 2018 and Nov 2024, across 77 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 32% of everything it billed.
33Billing provider infoNAZNEEN, RUKSANA
CHICAGO, IL 60649
CHICAGO, IL 60649
33aNPI1063432474assigned 07/20/2006
33bProvider typeFamily Medicine Physician
28Total paid$1.61M
24GClaims58,650
24DCodes billed77
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Family Medicine Physician providers in Illinois
Rank by total paid#57 of 2,947
Median peer was paid$43K
This provider vs. median38×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 19,095 | $452K | |
| 2019 | 25,921 | $715K | |
| 2020 | 12,243 | $347K | |
| 2021 | 320 | $18K | |
| 2022 | 436 | $28K | |
| 2023 | 324 | $22K | |
| 2024incomplete | 311 | $26K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 32% | 12,237 | 7,521 | $520K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 3,717 | 2,761 | $251K |
| 96127 | 9.3% | 10,799 | 6,973 | $150K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 4.9% | 1,193 | 799 | $78K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.9% | 977 | 641 | $62K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3.0% | 1,155 | 776 | $49K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2.7% | 599 | 337 | $43K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.6% | 1,045 | 826 | $41K |
| 99243 | 2.5% | 638 | 456 | $40K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 2.1% | 493 | 312 | $34K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.0% | 506 | 382 | $31K |
| 92551 | 1.5% | 1,711 | 1,017 | $25K |
65 more codes
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1.3% | 480 | $21K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 1.2% | 194 | $19K |
| 99401 | <1% | 620 | $15K | |
| 87503 | <1% | 910 | $15K | |
| 99385 | <1% | 143 | $14K | |
| 99173 | <1% | 1,797 | $13K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 159 | $12K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 745 | $12K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 144 | $11K |
| 82607 | <1% | 802 | $9K | |
| 80053 | Comprehensive metabolic panel | <1% | 834 | $8K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 923 | $8K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 192 | $7K |
| 87070 | <1% | 1,127 | $7K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 179 | $7K |
| 80061 | Lipid panel | <1% | 1,151 | $7K |
| 87186 | <1% | 592 | $7K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,088 | $7K |
| 83721 | <1% | 606 | $5K | |
| 86696 | <1% | 136 | $5K | |
| 87088 | <1% | 465 | $5K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 174 | $5K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 481 | $5K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 847 | $5K |
| 86695 | <1% | 149 | $4K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 57 | $4K |
| 99384 | <1% | 41 | $4K | |
| 99383 | <1% | 35 | $3K | |
| 84439 | <1% | 348 | $3K | |
| 84480 | <1% | 299 | $3K | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 100 | $2K |
| 84436 | <1% | 374 | $2K | |
| 86694 | <1% | 105 | $2K | |
| 86704 | <1% | 141 | $2K | |
| 87077 | <1% | 536 | $2K | |
| 94760 | <1% | 3,186 | $2K | |
| 86706 | <1% | 139 | $2K | |
| 81002 | <1% | 797 | $2K | |
| 86780 | <1% | 103 | $2K | |
| 84479 | <1% | 220 | $1K | |
| 80050 | General health panel | <1% | 216 | $1K |
| 81001 | <1% | 428 | $1K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 42 | $1K |
| 81025 | <1% | 388 | $957.21 | |
| 84481 | <1% | 86 | $860.48 | |
| 86803 | <1% | 40 | $674.00 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 228 | $631.29 |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 12 | $565.40 |
| 87340 | <1% | 40 | $540.00 | |
| 86705 | <1% | 35 | $539.00 | |
| 87255 | <1% | 30 | $520.52 | |
| 82962 | <1% | 275 | $438.48 | |
| 87081 | <1% | 66 | $382.80 | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 14 | $326.15 |
| 82746 | <1% | 25 | $286.50 | |
| 97597 | <1% | 14 | $250.02 | |
| 90734 | <1% | 15 | $213.95 | |
| 90656 | <1% | 17 | $170.39 | |
| 86592 | <1% | 38 | $152.00 | |
| 90658 | <1% | 16 | $146.40 | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 16 | $140.59 |
| 82570 | <1% | 28 | $130.48 | |
| 82043 | <1% | 28 | $110.32 | |
| 85018 | <1% | 31 | $69.60 | |
| 99000 | 0% | 33 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.